期刊文献+

奈韦拉平抗病毒治疗药物不良反应与CD4+淋巴细胞计数的关系 被引量:4

Correlation Between the Adverse Effects Associated with the Use of Nevirapine and CD4+ Lymphocyte Count
下载PDF
导出
摘要 目的分析服用奈韦拉平(NVP)组抗逆转录病毒治疗艾滋病患者中,使用奈韦拉平初治发生皮疹和肝损害的情况统计及相应处理对策。方法将170例艾滋病患者按CD4+T淋巴细胞计数水平的多少分为两组。A组CD4+细胞计数<200个/μL的患者,B组CD4+细胞计数≥200个/μL的患者,两组初治患者使用以下方案:齐多夫定+拉米夫定+奈韦拉平或替诺福韦+拉米夫定+奈韦拉平或司他夫定+拉米夫定+奈韦拉平。分别与治疗前治疗后半个月,1个月,2个月,3个月,监测肝功能,血常规,CD4+T淋巴计数,监测有无皮疹变化。分析两组3个月内的肝功能变化观察皮疹情况。分析皮疹及肝损害发生与CD4+细胞计数的关系。结果 A组皮疹发生率为24.7%,B组皮疹发生率为54.1%,差异均有统计学意义(P<0.001);A组肝损害发生率为12.9%,B组肝损害发生率为25.9%,差异均有统计学意义(P<0.05)。结论服用奈韦拉平皮疹和肝损害的发生率与CD4+细胞计数有关。 Objective To analyze the incidences of adverse effects associated with rash and liver damage in AIDS patients receiv-ing nevirapine-containing antiretroviral therapy and the corresponding countermeasures. Methods A total of 170 AIDS patients were divided into two groups by the CD4+ T cell count. In group A patients, CD4+cell count 〈200 cells/μl; and in group B pa-tients, CD4+cell count ≧200 cells/μl. Both of the groups' patients used the scheme below:zidovudine + lamivudine + nevirapine/tenofovir + lamivudine + nevirapine /stavudine + lamivudine + nevirapine. The correlation between adverse reactions and CD4+cell count was analyzed by comparing the results of liver function, routine blood test, CD4+ T cell count and skin rash before and after half month, one month and three-month treatment. Results The incidence of rash is 24.7% in group A and 54.1% in group B, respectively, the difference is statistically significant (P〈0.001). The incidence of liver damage is 12.9%in group A and 25.9%in group B, respectively, the difference is statistically significant (P〈0.05). Conclusion The incidences of rash and liver damage correlate with CD4+cell count in AIDS patients receiving nevirapine therapy.
出处 《中外医疗》 2014年第10期34-35,共2页 China & Foreign Medical Treatment
关键词 艾滋病 奈韦拉平 肝损害 抗逆转录病毒治疗 AIDS Nevirapine Liver damage Antiretroviral therapy
  • 相关文献

参考文献7

  • 1张福杰.国家免费制止并抗病毒药物治疗手册[M].3版.北京:人民卫生出版社.2012:109-117.
  • 2Warren KJ,Boxwell DE,Kim NY,et al.Nevirapine-associated stevens- Johnson [Jl.Lancet,1998,351 (2):567.
  • 3Dodi F,Alessandrini A,Camera M,et al.Stevens-Johnson syndrome in HIV patients with nevirapne:two case ports [J].AIDS,2002,16 (5):1197- 1198.
  • 4Cattelan AM,Trevenzoli M,sasset 1,et al.toxic Epider-mal Necrolysis Induced By Nevirapine therapy:description of two cases and reiew of the literarure[J].Journal of infection,2001,43(11):246-254.
  • 5Shenton JM,Teranishi M,Abu-Asab Ms,et ai.Characteriza-tion of potrutial animal model of an idiosyncratic drug reaction :nerirapinr- induced skin rash in the rat[J]. Chem ResToxicol,2003,16(7): 1078-1089.
  • 6涂国刚,李少华.非核苷类逆转录酶抑制剂奈韦拉平[J].中国临床药理学与治疗学,2003,8(6):604-607. 被引量:18
  • 7赵晓云,孙洪清,刘昔年.高效抗逆转录病毒治疗艾滋病导致的肝脏损伤[J].大连大学学报,2006,27(4):45-46. 被引量:6

二级参考文献33

  • 1[1]Hargrave KD, Proudfoot JR, Adams J, et al . 5.11-Dihydro-6H-dipyrido (3,2-B:2',3'-E)(1,4) diazepines and their use in the prevention or treatment of HIV infection[S]. US.Cl 514/220,5366972.1994.12
  • 2[2]Temesgen Z, Wright AJ. Antiretrovirals[J]. Mayo Clin Proc, 1999;74:1284-301
  • 3[3]Voelker R. New HIV drugs cast in supporting roles[J]. JAMA ,1996; 276:585-6
  • 4[4]Guay LA, Musoke P, Fleming T , et al. Intrapartum and neonatal single-dose nevirapine compared with zidovndine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial[J]. Lancet, 1999;354:795-802
  • 5[5]Marseille E, Kohn JG, Mmiro F, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa[J].Lancet,1999;354:803-9
  • 6[6]Schneider H, Christmann A. Process for preparing nevirapine[S]. US.Cl.540/495. 5569760.1996.10
  • 7[7]Kohlstaedt LA, Wang J, Friedman JM, et al. Crystal structure at 3.5? resolution of HIV-1 reverse transicriptase complexed with an inhibitor[J]. Science,1992;256:1783-90
  • 8[8]Wu JC, Warren TC, Adams J, et al. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site [J]. Biochemistry, 1991;30:2022-6
  • 9[9]Palladino DEH, Hopkins JL, Ingraham RH, et al. High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transeriptase of human immunodeficiency virs type-1[J]. J Chromatogr A, 1994;676:99-112
  • 10[10]Hannongbua S, Prasithichokekul S, Pungpo P. Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculations[J]. J Comput Alided Mol Des, 2002;15:997-1004

共引文献20

同被引文献35

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部